By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


American Society of Clinical Oncology 

225 Reinekers Lane
Suite 650
Alexandria  Virginia  22314  U.S.A.
Phone: 703-299-0150 Fax: 703-299-1044


Company News
Cleveland Biolabs Inc. (CBLI) Announces Acceptance Of Entolimod Phase 1 Study Findings For Poster Presentation At ASCO 4/24/2015 1:55:58 PM
CTI BioPharma And Baxter International (BAX) Announce Phase 3 Data Of Pacritinib In Patients With Myelofibrosis To Be Presented In Late-Breaking Session At ASCO 4/23/2015 12:38:14 PM
Calithera Biosciences, Inc. (CALA) Announces Clinical Data Presentation At ASCO 2015 4/22/2015 10:51:31 AM
Asterias Biotherapeutics Announces Phase 2 Clinical Data On Autologous Telomerase-Based Dendritic Cell Cancer Vaccine AST-VAC1 Selected For Oral Presentation At The 2015 ASCO Annual Meeting 4/22/2015 10:30:19 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Abstracts Accepted For Presentation At The 2015 ASCO Annual Meeting 4/21/2015 10:27:43 AM
Halozyme Therapeutics, Inc. (HALO) Presents New Preclinical Data At AACR Annual Meeting, Announces Clinical Data Presentation At ASCO 4/20/2015 11:11:15 AM
Argos Therapeutics, Inc. (ARGS) To Present Update On Pivotal Phase 3 ADAPT Clinical Trial During 2015 ASCO Annual Meeting 4/20/2015 7:47:27 AM
Cancer Network's Top Stories From the 2015 ASCO GU Cancers Symposium 3/12/2015 11:39:37 AM
TRACON Pharmaceuticals, Inc. (TCON) Announces Positive Phase 1b Results For TRC105 In Combination With Inlyta (Axitinib) At The ASCO 2015 Genitourinary Cancers Symposium 3/2/2015 7:06:30 AM
Argos Therapeutics, Inc. (ARGS) Announces Update On Phase 3 ADAPT Trial To Be Presented During 2015 ASCO Genitourinary Cancers Symposium 2/27/2015 7:14:23 AM